ATE304851T1 - Zusammensetzung die substituierte benzimidazole enthält - Google Patents

Zusammensetzung die substituierte benzimidazole enthält

Info

Publication number
ATE304851T1
ATE304851T1 AT00973295T AT00973295T ATE304851T1 AT E304851 T1 ATE304851 T1 AT E304851T1 AT 00973295 T AT00973295 T AT 00973295T AT 00973295 T AT00973295 T AT 00973295T AT E304851 T1 ATE304851 T1 AT E304851T1
Authority
AT
Austria
Prior art keywords
composition containing
containing substituted
substituted benzimidazoles
benzimidazoles
composition
Prior art date
Application number
AT00973295T
Other languages
German (de)
English (en)
Inventor
Mikael Bruells
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE304851T1 publication Critical patent/ATE304851T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00973295T 1999-10-22 2000-10-13 Zusammensetzung die substituierte benzimidazole enthält ATE304851T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles
PCT/SE2000/001992 WO2001028558A1 (en) 1999-10-22 2000-10-13 Formulation of substituted benzimidazoles

Publications (1)

Publication Number Publication Date
ATE304851T1 true ATE304851T1 (de) 2005-10-15

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973295T ATE304851T1 (de) 1999-10-22 2000-10-13 Zusammensetzung die substituierte benzimidazole enthält

Country Status (35)

Country Link
US (1) US6730685B1 (enExample)
EP (1) EP1274427B1 (enExample)
JP (1) JP2003512327A (enExample)
KR (1) KR100785603B1 (enExample)
CN (1) CN1213751C (enExample)
AR (1) AR029005A1 (enExample)
AT (1) ATE304851T1 (enExample)
AU (1) AU782866B2 (enExample)
BG (1) BG65580B1 (enExample)
BR (1) BR0014895A (enExample)
CA (1) CA2425199C (enExample)
CO (1) CO5261533A1 (enExample)
CY (1) CY1106055T1 (enExample)
CZ (1) CZ20021375A3 (enExample)
DE (1) DE60022789T2 (enExample)
DK (1) DK1274427T3 (enExample)
EE (1) EE05175B1 (enExample)
ES (1) ES2246903T3 (enExample)
HU (1) HUP0203121A3 (enExample)
IL (2) IL149107A0 (enExample)
IS (1) IS2196B (enExample)
MX (1) MXPA02003900A (enExample)
MY (1) MY131971A (enExample)
NO (1) NO329545B1 (enExample)
NZ (1) NZ518155A (enExample)
PL (1) PL199868B1 (enExample)
RU (1) RU2286782C2 (enExample)
SE (1) SE9903831D0 (enExample)
SI (1) SI1274427T1 (enExample)
SK (1) SK286266B6 (enExample)
TR (1) TR200201103T2 (enExample)
TW (1) TWI236372B (enExample)
UA (1) UA74347C2 (enExample)
WO (1) WO2001028558A1 (enExample)
ZA (1) ZA200202905B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001276721A1 (en) * 2000-08-04 2002-02-18 Takeda Chemical Industries Ltd. Salts of benzimidazole compound and use thereof
WO2002015908A1 (en) * 2000-08-18 2002-02-28 Takeda Chemical Industries, Ltd. Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
MXPA04002973A (es) 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosis de liberacion modificada.
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
CN100558726C (zh) * 2003-02-24 2009-11-11 田边三菱制药株式会社 泰妥拉唑的对映体及其在治疗中的应用
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
AU2007248949B2 (en) * 2006-05-09 2010-04-08 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
JP6698651B2 (ja) 2014-11-13 2020-05-27 スリーエム イノベイティブ プロパティズ カンパニー 試料中の細菌ａｔｐを検出するためのａｔｐ−ジホスホヒドロラーゼを含むキット
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2025078989A1 (en) * 2023-10-11 2025-04-17 Reena Patel Stabilized pharmaceutical compositions
WO2025181379A1 (en) * 2024-03-01 2025-09-04 Etico Lifesciences Private Limited Liquid, storage stable, directly injectable, pantoprazole formulations, their uses and manufacturing

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
SG52479A1 (en) 1992-07-28 1998-09-28 Astra Ab Injection and injection kit containing omeprazole and its analogs
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
US6287594B1 (en) * 1998-01-20 2001-09-11 Edward S. Wilson Oral liquid compositions

Also Published As

Publication number Publication date
IL149107A (en) 2008-04-13
US6730685B1 (en) 2004-05-04
IS6347A (is) 2002-04-17
MXPA02003900A (es) 2002-09-30
CY1106055T1 (el) 2011-04-06
CO5261533A1 (es) 2003-03-31
ES2246903T3 (es) 2006-03-01
PL354926A1 (en) 2004-03-22
TWI236372B (en) 2005-07-21
CA2425199C (en) 2010-12-07
CZ20021375A3 (cs) 2002-09-11
HUP0203121A3 (en) 2004-01-28
EE200200204A (et) 2003-04-15
CA2425199A1 (en) 2001-04-26
BG65580B1 (bg) 2009-01-30
KR100785603B1 (ko) 2007-12-14
BG106602A (en) 2002-12-29
HK1051142A1 (en) 2003-07-25
PL199868B1 (pl) 2008-11-28
SK5392002A3 (en) 2002-10-08
BR0014895A (pt) 2002-06-18
AR029005A1 (es) 2003-06-04
RU2286782C2 (ru) 2006-11-10
CN1213751C (zh) 2005-08-10
SK286266B6 (sk) 2008-06-06
NO329545B1 (no) 2010-11-08
HUP0203121A2 (hu) 2003-01-28
ZA200202905B (en) 2003-07-14
KR20020059637A (ko) 2002-07-13
AU1182301A (en) 2001-04-30
DK1274427T3 (da) 2005-12-27
SE9903831D0 (sv) 1999-10-22
TR200201103T2 (tr) 2002-08-21
IL149107A0 (en) 2002-11-10
EE05175B1 (et) 2009-06-15
NO20021860D0 (no) 2002-04-19
UA74347C2 (uk) 2005-12-15
NO20021860L (no) 2002-05-21
IS2196B (is) 2007-01-15
WO2001028558A1 (en) 2001-04-26
CN1382048A (zh) 2002-11-27
SI1274427T1 (sl) 2006-02-28
EP1274427A1 (en) 2003-01-15
NZ518155A (en) 2004-07-30
JP2003512327A (ja) 2003-04-02
AU782866B2 (en) 2005-09-01
MY131971A (en) 2007-09-28
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
EP1274427B1 (en) 2005-09-21

Similar Documents

Publication Publication Date Title
DE60022789D1 (de) Zusammensetzung die substituierte benzimidazole enthält
DE60022386D1 (de) Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten
DE60003709D1 (de) Substituierte azole
DE60336811D1 (de) Neue benzimidazolderivate
DE60207390D1 (de) Entzündungshemmende benzimidazolverbindungen
IS6120A (is) Lyfjablanda
NO20033715L (no) Nye sammensetninger
ATE299507T1 (de) Bizyklische heteroaromatische verbindungen als lh-agonisten
ATE291575T1 (de) N-carbamoyloxyalkyl-substituierte azolium- verbindungen
ATE246700T1 (de) Benzimidazolderivate
DE69935620D1 (de) Aufzug
ATE386518T1 (de) Benzimidazolderivate
NO20015074L (no) Nye sammensetninger
DE69931821D1 (de) Wärmehärtbare pulverlack-zusammensetzung
DE69943245D1 (de) Gaserzeugende zusammensetzung
ATE264301T1 (de) Muscarin-antagonisten
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
ATA98999A (de) Strangführungsrolle
ATE280161T1 (de) Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten
ID27329A (id) Komposisi penghambat
DE60001217D1 (de) Extrusionsdüse
DE50000511D1 (de) Extruderdüsenkopf
DE60007483D1 (de) Aufzug
DE60012953D1 (de) 3-amino-2-phenylpiperidinderivate als substanz p antagonisten
FI991630L (fi) Laitteisto viilujen pinkkaamiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1274427

Country of ref document: EP